J&J CEO talks about M&A and ongoing restructuring in med device businesses

J&J CEO: On Track With Restructuring, Very Disciplined In M&A (MedDeviceOnline)

Johnson & Johnson CEO Alex Gorsky says that J&J is on track and reaping gains from the restructuring of its medical device business, six months after it announced accelerated innovation to keep up with market changes. Senior leadership also will continue to be very disciplined in evaluating M&A deals, in spite of the company's deep pockets.
In January, J&J announced that it will streamline its workforce and certain offerings in the orthopedics, surgery, and cardiovascular segments in order ...